Technical Analysis for CODX - Co-Diagnostics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.11 | -2.63% | -0.03 |
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| 50 DMA Resistance | Bearish | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -2.63% | |
| 50 DMA Resistance | Bearish | -2.63% | |
| 20 DMA Resistance | Bearish | -2.63% | |
| 50 DMA Resistance | Bearish | -2.63% | |
| MACD Bearish Centerline Cross | Bearish | -2.63% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 12 hours ago |
| 50 DMA Resistance | about 12 hours ago |
| 60 Minute Opening Range Breakout | about 14 hours ago |
| Rose Above Previous Day's High | about 14 hours ago |
| Up 3% | about 14 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/09/2024
Co-Diagnostics, Inc. Description
Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Clinical Medicine Disease Acid Hepatitis B Medical Test Diagnostic Tests Molecular Diagnostics Genetic Diseases Immunodeficiency Malaria Organisms Diagnostic Equipment Polymerase Chain Reaction Tuberculosis Ortho Clinical Diagnostics Dengue Zika Dengue Fever
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.88 |
| 52 Week Low | 0.975 |
| Average Volume | 58,628 |
| 200-Day Moving Average | 1.21 |
| 50-Day Moving Average | 1.15 |
| 20-Day Moving Average | 1.17 |
| 10-Day Moving Average | 1.15 |
| Average True Range | 0.06 |
| RSI (14) | 41.52 |
| ADX | 14.43 |
| +DI | 12.57 |
| -DI | 19.48 |
| Chandelier Exit (Long, 3 ATRs) | 1.11 |
| Chandelier Exit (Short, 3 ATRs) | 1.25 |
| Upper Bollinger Bands | 1.26 |
| Lower Bollinger Band | 1.07 |
| Percent B (%b) | 0.2 |
| BandWidth | 15.86 |
| MACD Line | -0.01 |
| MACD Signal Line | 0.00 |
| MACD Histogram | -0.0076 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.21 | ||||
| Resistance 3 (R3) | 1.23 | 1.20 | 1.20 | ||
| Resistance 2 (R2) | 1.20 | 1.18 | 1.20 | 1.19 | |
| Resistance 1 (R1) | 1.16 | 1.16 | 1.14 | 1.14 | 1.19 |
| Pivot Point | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 |
| Support 1 (S1) | 1.09 | 1.11 | 1.08 | 1.08 | 1.03 |
| Support 2 (S2) | 1.06 | 1.09 | 1.06 | 1.03 | |
| Support 3 (S3) | 1.02 | 1.06 | 1.02 | ||
| Support 4 (S4) | 1.01 |
